CNS Pharmaceuticals, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
CNSP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2100 West Loop South, Suite 900, Houston, TX

Insiders trading volume in the past year

CNS Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John M. Climaco Chief Executive Officer, Director $233K +$50K +27.4% Apr 8, 2024
Waldemar Priebe 10%+ Owner $198K Dec 6, 2022
Cortice Biosciences, Inc. 10%+ Owner $172K Jul 30, 2024
Jerzy Gumulka Director $57.2K +$10K +21.2% Apr 8, 2024
Carl Anthony Evans Director $54.2K +$10K +22.6% Apr 8, 2024
Christopher Downs Chief Financial Officer $31.1K +$20K +180% Apr 8, 2024
Jeffry R. Keyes Director $24.1K Apr 8, 2024
Faith L. Charles Director $19.4K Apr 8, 2024
Bettina M. Cockroft Director $15.9K Apr 8, 2024
Amy Mahery Director $14.2K Apr 8, 2024
Andrzej Andraczke Director Sep 21, 2023

Recent Insider Transactions by Companies or Individuals for CNS Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.